Zivo Bioscience, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Zivo Bioscience, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2010 to Q3 2024.
  • Zivo Bioscience, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$2.27M, a 24.3% decline year-over-year.
  • Zivo Bioscience, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$13.7M, a 60.9% decline year-over-year.
  • Zivo Bioscience, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$7.78M, a 11.1% increase from 2022.
  • Zivo Bioscience, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$8.75M, a 0.12% increase from 2021.
  • Zivo Bioscience, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$8.76M, a 3.84% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$13.7M -$2.27M -$444K -24.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$13.2M -$8.24M -$6.17M -298% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$7.08M -$1.28M +$695K +35.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$7.78M -$1.91M +$732K +27.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 -$8.51M -$1.82M +$179K +8.95% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$8.69M -$2.07M +$1.27K +0.06% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$8.69M -$1.97M +$55.2K +2.72% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$8.75M -$2.64M +$499K +15.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 -$9.24M -$2M -$453K -29.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$8.79M -$2.07M -$226K -12.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$8.57M -$2.03M +$191K +8.59% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$8.76M -$3.14M -$1.25M -65.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 -$7.51M -$1.55M +$1.95M +55.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$9.46M -$1.85M -$679K -58.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$8.78M -$2.22M +$324K +12.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$9.11M -$1.89M +$2.24M +54.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-22
Q3 2020 -$11.3M -$3.5M -$1.72M -96.7% Jul 1, 2020 Sep 30, 2020 10-Q/A 2022-04-21
Q2 2020 -$9.62M -$1.17M +$1.37M +54.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$11M -$2.54M +$514K +16.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$11.5M -$4.13M -$1.03M -33.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$10.5M -$1.78M +$2.34M +56.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$12.8M -$2.54M +$1.03M +28.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$13.8M -$3.06M +$789K +20.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$14.6M -$3.1M +$783K +20.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-26
Q3 2018 -$15.4M -$4.12M -$1.25M -43.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-28
Q2 2018 -$14.2M -$3.57M -$2.15M -150% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$12M -$3.85M -$1.98M -107% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 -$10M -$3.88M -$2.65M -215% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-12
Q3 2017 -$7.39M -$2.87M -$1.73M -152% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$5.66M -$1.43M +$866K +37.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$6.53M -$1.86M -$469K -33.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-23
Q4 2016 -$6.06M -$1.23M -$215K -21.1% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-21
Q3 2016 -$5.85M -$1.14M +$334K +22.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-19
Q2 2016 -$6.18M -$2.29M -$284K -14.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$5.9M -$1.39M -$106K -8.24% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 -$5.79M -$1.02M -$1.74M -240% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-29
Q3 2015 -$4.05M -$1.47M +$1.87M +55.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$5.91M -$2.01M -$1.34M -201% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 -$4.57M -$1.29M -$5.25M -132% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 $681K $726K +$465K +178% Oct 1, 2014 Dec 31, 2014 10-K 2015-04-06
Q3 2014 $216K -$3.34M +$1.34M +28.6% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$1.12M -$668K +$4.08M +85.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$5.21M $3.96M +$4.89M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 -$10.1M $261K Oct 1, 2013 Dec 31, 2013 10-K 2015-04-06
Q3 2013 -$4.68M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$4.75M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$927K +$132K +12.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q1 2012 -$1.06M -$591K -127% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-06
Q3 2011 -$542K +$46.7K +7.93% Jul 1, 2011 Sep 30, 2011 10-Q 2011-11-21
Q1 2011 -$467K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$589K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.